Log in for full access to this activity, if you are registered.

Registration Options

Activity Dates: 04/21/2013 - 04/21/2016

This course is closed. Please look for other available products in CPNP University.

Target Audience

If you are a pharmacist, nurse practitioner or other healthcare professional involved in the comprehensive medication management of psychiatric and/or neurological patients, we invite you to participate in this online course.

Session Summary

Opioid use in pregnancy includes the use of heroin and the misuse or abuse of prescription opioid medications. Untreated opioid dependence during pregnancy can have devastating consequences to a developing fetus. Methadone maintenance has been the standard of care; however its use can lead to significant neonatal abstinence syndrome. Emerging evidence supports the use of buprenorphine for opioid maintenance during pregnancy. During the intrapartum and postpartum period, special considerations are needed for women who are opioid dependent to ensure appropriate pain management, to prevent relapse and to decrease risk of overdose. Breastfeeding should be encouraged in women who receive buprenorphine or methadone maintenance in the absence of HIV infection or other contraindications. Use of buprenorphine or methadone in pregnancy puts the neonate at risk of abstinence syndrome, which is characterized by hyperactivity of the central and autonomic nervous systems. This educational session will contrast the risks and benefits associated with use of buprenorphine or methadone in pregnant women.

Course Requirements

You will proceed through the following steps to satisfactorily complete this course:

  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date. (login first)
  • Complete the evaluation at the end of the activity. (login first)
  • Receive a passing grade (60%).
  • Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

This course is provided online at cpnp.org and consists of the speaker audio and slides. A PDF file of the slides is also provided and access is available to participants indefinitely although ACPE credit is available only through the course expiration date.

Participants in this course must complete an examination and achieve a score of 60% or greater. Successful completion of the course also requires the completion of a course evaluation. ACPE statements of credit can be retrieved by participants online at cpnp.org immediately upon successful completion of the course.

Faculty Information and Disclosures

Learning Objectives

  1. Evaluate evidence-based literature regarding treatment of opioid dependency during pregnancy with buprenorphine or methadone.
  2. Contrast the benefits and disadvantages associated with use of buprenorphine or methadone in pregnant women.
  3. Discuss the management of intrapartum and postpartum pain in opioid dependent patients.
  4. Examine the incidence and treatment of neonatal abstinence syndrome associated with buprenorphine and methadone use in pregnancy.
  5. Provide medication education to patients and families of pregnant women with opioid dependence.

Continuing Education Credit and Disclosures

Activity Dates: 04/21/2013 - 04/21/2016
ACPE Contact Hours: 2.0
ACPE Number: 0284-0000-13-002-H01-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This self-study course provides 2.0 contact hours (0.02 CEUs) of knowledge-based continuing education credit from CPNP approved programming. The ACPE universal program number assigned to this course is 0284-000-13-002-L01-P (2.0 contact hours).

ACPE approved contact hours are accepted for ANCC Certification Renewal (see pages 5 and 6): At least 50% (37.5 hours) of your 75 continuing education hours must be formally approved continuing education hours. Formally approved continuing education hours meet one or more of the criteria listed below:

  1. Continuing nursing education (CNE) approved for nursing contact hours by an accredited provider or approver of nursing continuing education
  2. Continuing medical education (CME) approved for CME hours
  3. Sponsored by organizations, agencies, or educational institutions accredited or approved by the American Nurses Credentialing Center (ANCC) or the Accreditation Council for Continuing Medical Education (ACCME) or the Accreditation Council for Pharmacy Education (ACPE) or the Commission on Dietetic Registration

Grant Support

Annual Meeting Grant Provider

Cyberonics

BCPP Recertification Grant Provider

Lilly

This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.